Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV Project Director, Treatment Action Group (TAG)
We’re being duped by our government agencies. We’re being hoodwinked by the Affordable Care Act (ACA).
A young HIV-positive man dies after being denied access to a lung transplant program in New York City, resulting in activism demanding a promp...
It is lamentable that an event attempting to look toward a brighter future should harken back to the dark days when people with HIV and commun...
Lack of access to care proves to be problem for people living with HIV in the United States and around the world.
Gilead’s experimental nucleotide reverse transcriptase inhibitor tenofovir alafenamide fumarate (TAF) is being studied as a component of next-...
With the specter of AIDS having finally been chased from the near horizon, attention has turned to health problems that may lie further down t...
The United States is on course for some much-needed economic relief from the crippling cost of HIV treatment.
We have until January 4 to convince the United States Preventive Services Task Force to issue strong hepatitis C testing recommendations...
If we’re going to make headway in terms of preventing and treating serious non-AIDS health complications among people living with HIV, which a...
The national portrait of entry into and retention in HIV care has been consistently abysmal
AIDS Healthcare Foundation’s campaign against the FDA approval of Truvada as PrEP is misplaced.
The second of a two-part look at the top treatment news of 2010.
The first of a two-part look at the top treatment news of 2010.
Scare tactics don’t work, especially when the goal is to get people living with HIV who are unaware of their status tested and into care.
The international iPrEx study confirms that PrEP works, though not at the level researchers were initially hoping.
Egrifta (tesamorelin) has been approved for the treatment of HIV-associated lipodystrophy. The question is, will a possible high price tag kee...
For New York voters still torn between the gubernatorial front-runners, Democratic candidate Andrew Cuomo and Republican candidate Paladino
A safe and affordable cure for HIV -- whether it’s a single agent or, more realistically, a combination of modalities -- won’t be on the U.S....
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.